Pulmonary embolism epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
 
(52 intermediate revisions by 11 users not shown)
Line 1: Line 1:
__NOTOC__
{| class="infobox" style="float:right;"
|-
| [[File:Siren.gif|30px|link=Pulmonary embolism resident survival guide]]|| <br> || <br>
| [[Pulmonary embolism resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
|}
{{Pulmonary embolism}}
{{Pulmonary embolism}}
 
{{CMG}} {{ATI}}; {{AE}} {{Rim}}
{{CMG}}
'''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]


==Overview==
==Overview==
Each year in United States, there are between 300,000 and 600,000 cases of pulmonary embolism (PE). If un-treated almost 1/3 of patient die, usually from recurrent PE. However, with prompt diagnosis and treatment, the mortality rate is only ~ 2 – 8%. Unfortunately, 2/3 of all cases of PE are diagnosed only on autopsy. [http://stopdvt.org/Documents/AMA%20Fact%20Sheet%20Current%20Research.pdf] PE is the major contributing factor or a cause of death in 16% of the hospitalized patients.
The precise number of people affected by [[venous thromboembolism]](VTE), that is either [[deep vein thrombosis]], pulmonary embolism (PE), or both, is unknown, but estimates range from 300,000 to 600,000 (1 to 2 per 1,000, and in those over 80 years of age, as high as 1 in 100) each year in the United States.  Approximately 5 to 8% of the U.S. population has one of several [[genetic]] risk factors, also known as [[inherited]] [[thrombophilia]]s in which a [[genetic]] defect can be identified that increases the risk for [[thrombosis]].<ref name=CDC>[http://www.cdc.gov/ncbddd/dvt/data.html CDC- Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE) — Blood Clot Forming in a Vein]</ref><ref name="pmid20331949">{{cite journal| author=Beckman MG, Hooper WC, Critchley SE, Ortel TL| title=Venous thromboembolism: a public health concern. | journal=Am J Prev Med | year= 2010 | volume= 38 | issue= 4 Suppl | pages= S495-501 | pmid=20331949 | doi=10.1016/j.amepre.2009.12.017 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20331949  }} </ref>


==Epidemiology and Demographics==
==Epidemiology and Demographics==
''Horlander et al'' analyzed multiple-cause mortality files compiled by the National Center for Health Statistics from 1979 to 1998. They reported that out of 42932973 deaths that occurred, almost 600,000 patients (approximately 1.5 percent) had been diagnosed with PE, and it was the presumed cause of death in 200,00 patients.<ref name="pmid12885687">{{cite journal| author=Horlander KT, Mannino DM, Leeper KV| title=Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. | journal=Arch Intern Med | year= 2003 |volume= 163 | issue= 14 | pages= 1711-7 | pmid=12885687 | doi=10.1001/archinte.163.14.1711 | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12885687 }}</ref>
===Incidence===
* The precise number of people affected by [[venous thromboembolism]] (VTE), that is either [[deep vein thrombosis]] (DVT), [[pulmonary embolism]] (PE), or both, is unknown, but estimates range from 300,000 to 600,000 (1 to 2 per 1,000, and in those over 80 years of age, as high as 1 in 100) each year in the United States.<ref name=CDC>[http://www.cdc.gov/ncbddd/dvt/data.html CDC- Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE) — Blood Clot Forming in a Vein]</ref><ref name="pmid20331949">{{cite journal| author=Beckman MG, Hooper WC, Critchley SE, Ortel TL| title=Venous thromboembolism: a public health concern. | journal=Am J Prev Med | year= 2010 | volume= 38 | issue= 4 Suppl | pages= S495-501 | pmid=20331949 | doi=10.1016/j.amepre.2009.12.017 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20331949  }} </ref>
 
* In the United States, the annual incidence of VTE is estimated to be approximately 100 per 100,000 persons.<ref name="pmid12814979">{{cite journal |author=White RH |title=The epidemiology of venous thromboembolism |journal=Circulation |volume=107 |issue=23 Suppl 1 |pages=I4–8 |year=2003 |month=June |pmid=12814979 |doi=10.1161/01.CIR.0000078468.11849.66 |url=}}</ref>
 
===Age===
The incidence of [[VTE]] increases with age, ranging from < 5 cases per 100,000 people in childhood to 500 cases per 100,000 people in the elderly.<ref name="pmid12814979">{{cite journal |author=White RH |title=The epidemiology of venous thromboembolism |journal=Circulation |volume=107 |issue=23 Suppl 1 |pages=I4–8 |year=2003 |month=June |pmid=12814979 |doi=10.1161/01.CIR.0000078468.11849.66 |url=}}</ref> Subjects who are more than 65 years of age are at three times higher risk for VTE compared to those who are 45-54 years old.<ref name="pmid15210384">{{cite journal| author=Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P et al.| title=Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. | journal=Am J Med | year= 2004 | volume= 117 | issue= 1 | pages= 19-25 | pmid=15210384 | doi=10.1016/j.amjmed.2004.01.018 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15210384  }} </ref>
 
===Gender===
Studies about differences in the incidence of [[VTE]] by gender have mixed results.<ref name="pmid9521222">{{cite journal |author=Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ |title=Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study |journal=Arch. Intern. Med. |volume=158 |issue=6 |pages=585–93 |year=1998 |month=March |pmid=9521222 |doi= |url=}}</ref><ref name="pmid8154949">{{cite journal |author=Kniffin WD, Baron JA, Barrett J, Birkmeyer JD, Anderson FA |title=The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly |journal=Arch. Intern. Med. |volume=154 |issue=8 |pages=861–6 |year=1994 |month=April |pmid=8154949 |doi= |url=}}</ref><ref name="pmid15210384">{{cite journal |author=Cushman M, Tsai AW, White RH, ''et al.'' |title=Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology |journal=Am. J. Med. |volume=117 |issue=1 |pages=19–25 |year=2004 |month=July |pmid=15210384 |doi=10.1016/j.amjmed.2004.01.018 |url=}}</ref><ref name="urlVenous Thromboembolism in Adult Hospitalizations — United States, 2007–2009">{{cite web |url=http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6122a1.htm?s_cid=mm6122a1_w |title=Venous Thromboembolism in Adult Hospitalizations — United States, 2007–2009 |format= |work= |accessdate=2012-10-06}}</ref> In addition, the risk for [[VTE]] was reported to consistently increase with age across both genders.<ref name="pmid15210384">{{cite journal |author=Cushman M, Tsai AW, White RH, ''et al.'' |title=Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology |journal=Am. J. Med. |volume=117 |issue=1 |pages=19–25 |year=2004 |month=July |pmid=15210384 |doi=10.1016/j.amjmed.2004.01.018 |url=}}</ref>


The incidence  [[Pulmonary embolism classification scheme#Massive PE|massive]], [[Pulmonary embolism classification scheme#Submassive PE|submassive]] and  [[Pulmonary embolism classification scheme#Low-risk PE|low-risk]] are 5%, 40% and 55% respectively.  
===Race===
* There is a significant difference in the incidence of [[VTE]] as it relates to race. African Americans characteristically have the highest incidence of [[VTE]] and Caucasians rank as the second highest incidence of [[VTE]].<ref name="pmid12814979">{{cite journal| author=White RH| title=The epidemiology of venous thromboembolism. | journal=Circulation | year= 2003 | volume= 107 | issue= 23 Suppl 1 | pages= I4-8 | pmid=12814979 | doi=10.1161/01.CIR.0000078468.11849.66 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12814979  }} </ref>
* Lower thrombosis incidences in non-Caucasians may be related to a lower prevalence of disorders like [[Factor V Leiden]] or [[Thrombin#Prothrombin 20210a mutation|Prothrombin 20210A mutation]].<ref name="pmid9109469">{{cite journal| author=Ridker PM, Miletich JP, Hennekens CH, Buring JE| title=Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. | journal=JAMA | year= 1997 | volume= 277 | issue= 16 | pages= 1305-7 | pmid=9109469 | doi= | pmc= | url= }} </ref><ref name="pmid9415695">{{cite journal| author=Gregg JP, Yamane AJ, Grody WW| title=Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. | journal=Am J Med Genet | year= 1997 | volume= 73 | issue= 3 | pages= 334-6 | pmid=9415695 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9415695  }} </ref>


Only 10-20% of VTE is clinically recognized, as depicted by the figure below.
===Percent Distribution of VTE by Subtypes===
* As depicted by the figure below, the majority of [[VTE]] events is [[asymptomatic]]; while some cases present with [[fatal]] [[PE]].


[[File:Challenge of Assessing VTE.JPG|300x400px]]
[[File:Challenge of Assessing VTE.JPG|300x400px]]
* The percentages of the different subtypes of PE are:
** Massive PE: 5-10%
** Submassive PE: 20-25%
** Low-risk PE: ~70%


==References==
==References==
{{reflist|2}}
{{Reflist|2}}
{{WH}}
 
{{WS}}


[[Category:Hematology]]
[[Category:Hematology]]
Line 25: Line 45:
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Up-To-Date]]
 
[[Category:Up-To-Date cardiology]]
{{WH}}
{{WS}}

Latest revision as of 13:47, 11 October 2017



Resident
Survival
Guide

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism epidemiology and demographics

CDC on Pulmonary embolism epidemiology and demographics

Pulmonary embolism epidemiology and demographics in the news

Blogs on Pulmonary embolism epidemiology and demographics

Directions to Hospitals Treating Pulmonary embolism epidemiology and demographics

Risk calculators and risk factors for Pulmonary embolism epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] The APEX Trial Investigators; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

The precise number of people affected by venous thromboembolism(VTE), that is either deep vein thrombosis, pulmonary embolism (PE), or both, is unknown, but estimates range from 300,000 to 600,000 (1 to 2 per 1,000, and in those over 80 years of age, as high as 1 in 100) each year in the United States. Approximately 5 to 8% of the U.S. population has one of several genetic risk factors, also known as inherited thrombophilias in which a genetic defect can be identified that increases the risk for thrombosis.[1][2]

Epidemiology and Demographics

Incidence

  • In the United States, the annual incidence of VTE is estimated to be approximately 100 per 100,000 persons.[3]

Age

The incidence of VTE increases with age, ranging from < 5 cases per 100,000 people in childhood to 500 cases per 100,000 people in the elderly.[3] Subjects who are more than 65 years of age are at three times higher risk for VTE compared to those who are 45-54 years old.[4]

Gender

Studies about differences in the incidence of VTE by gender have mixed results.[5][6][4][7] In addition, the risk for VTE was reported to consistently increase with age across both genders.[4]

Race

  • There is a significant difference in the incidence of VTE as it relates to race. African Americans characteristically have the highest incidence of VTE and Caucasians rank as the second highest incidence of VTE.[3]
  • Lower thrombosis incidences in non-Caucasians may be related to a lower prevalence of disorders like Factor V Leiden or Prothrombin 20210A mutation.[8][9]

Percent Distribution of VTE by Subtypes

  • As depicted by the figure below, the majority of VTE events is asymptomatic; while some cases present with fatal PE.

  • The percentages of the different subtypes of PE are:
    • Massive PE: 5-10%
    • Submassive PE: 20-25%
    • Low-risk PE: ~70%

References

  1. 1.0 1.1 CDC- Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE) — Blood Clot Forming in a Vein
  2. 2.0 2.1 Beckman MG, Hooper WC, Critchley SE, Ortel TL (2010). "Venous thromboembolism: a public health concern". Am J Prev Med. 38 (4 Suppl): S495–501. doi:10.1016/j.amepre.2009.12.017. PMID 20331949.
  3. 3.0 3.1 3.2 White RH (2003). "The epidemiology of venous thromboembolism". Circulation. 107 (23 Suppl 1): I4–8. doi:10.1161/01.CIR.0000078468.11849.66. PMID 12814979. Unknown parameter |month= ignored (help)
  4. 4.0 4.1 4.2 Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P; et al. (2004). "Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology". Am J Med. 117 (1): 19–25. doi:10.1016/j.amjmed.2004.01.018. PMID 15210384.
  5. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ (1998). "Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study". Arch. Intern. Med. 158 (6): 585–93. PMID 9521222. Unknown parameter |month= ignored (help)
  6. Kniffin WD, Baron JA, Barrett J, Birkmeyer JD, Anderson FA (1994). "The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly". Arch. Intern. Med. 154 (8): 861–6. PMID 8154949. Unknown parameter |month= ignored (help)
  7. "Venous Thromboembolism in Adult Hospitalizations — United States, 2007–2009". Retrieved 2012-10-06.
  8. Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997). "Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening". JAMA. 277 (16): 1305–7. PMID 9109469.
  9. Gregg JP, Yamane AJ, Grody WW (1997). "Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations". Am J Med Genet. 73 (3): 334–6. PMID 9415695.

Template:WH Template:WS